Published in Am J Health Behav on April 29, 2008
Human Laboratory Study Of Varenicline in Smokers | NCT00709696
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79
Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. JAMA (2016) 2.31
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry (2013) 2.11
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol (2010) 1.59
Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. J Pharmacol Exp Ther (2010) 1.24
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res (2010) 1.13
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice. PLoS One (2013) 1.04
Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat (2008) 1.03
Developing and validating a human laboratory model to screen medications for smoking cessation. Nicotine Tob Res (2012) 1.03
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol (2014) 0.94
Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients. Drug Healthc Patient Saf (2010) 0.86
Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence. J Exp Pharmacol (2009) 0.86
A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia. J Addict Res Ther (2011) 0.86
Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction (2015) 0.84
Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health (2015) 0.83
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction (2010) 0.82
Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers. Psychopharmacology (Berl) (2012) 0.81
Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery. Acta Pharmacol Sin (2015) 0.78
Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo. Psychopharmacology (Berl) (2017) 0.77
Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months. Nagoya J Med Sci (2016) 0.75
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation. Front Mol Neurosci (2015) 0.75
Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers. Adv Ther (2016) 0.75
Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol (2009) 0.75
Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation. Prev Med Rep (2015) 0.75
The Effect of Physicochemical Modification on the Function of Antibodies Induced by Anti-Nicotine Vaccine in Mice. Vaccines (Basel) (2017) 0.75
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA (2006) 5.19
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70
Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med (2006) 3.30
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin (2007) 2.75
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One (2011) 2.30
The clinical features of the overlap between COPD and asthma. Respir Res (2011) 2.29
Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clin Ther (2007) 2.06
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98
The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest (2005) 1.94
Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci (2007) 1.88
Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry (2004) 1.87
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet (2006) 1.84
Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol (2004) 1.82
CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci (2011) 1.63
Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet (2002) 1.62
Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety (2010) 1.58
Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine Tob Res (2006) 1.55
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54
A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction (2007) 1.48
Extended treatment of older cigarette smokers. Addiction (2009) 1.48
Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48
Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry (2002) 1.47
Should troponin and creatinine kinase be routinely measured after vascular surgery? Vasc Med (2007) 1.44
Religious and spiritual coping and quality of life among patients with emphysema in the National Emphysema Treatment Trial. Respir Care (2011) 1.40
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Curr Med Res Opin (2008) 1.39
Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD (2008) 1.38
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol (2009) 1.37
Attention deficit hyperactivity disorder in children and adolescents following traumatic brain injury. Dev Neuropsychol (2004) 1.36
Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci (2009) 1.27
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin Pharmacokinet (2010) 1.19
Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res (2009) 1.15
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15
Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res (2014) 1.14
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD (2007) 1.12
Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev (2004) 1.12
Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med (2011) 1.12
Eleven-year outcomes from an integrated residency program to train research psychiatrists. Acad Med (2013) 1.07
Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res (2014) 1.06
Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction (2005) 1.06
Publication ethics: an examination of authorship practices. Am J Health Behav (2005) 1.05
Retail promotions and perceptions of R.J. Reynolds' novel dissolvable tobacco in a US test market. Harm Reduct J (2011) 1.05
Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry (2006) 1.05
Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res (2005) 1.03
Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol (2009) 1.03
Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations. Biol Psychiatry (2006) 1.02
α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest (2010) 1.02
Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet (2004) 1.01
Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD. Respir Med (2013) 1.00
Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00
Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.98
Using extended cognitive behavioral treatment and medication to treat dependent smokers. Am J Public Health (2011) 0.97
Recent trends in american board of psychiatry and neurology psychiatric subspecialties. Acad Psychiatry (2011) 0.97
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med (2011) 0.96
Wildfire smoke and respiratory symptoms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2005) 0.96
CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. PLoS One (2013) 0.94
FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc (2014) 0.93
Bupropion SR for the treatment of smokeless tobacco use. Drug Alcohol Depend (2007) 0.93
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med (2014) 0.93
A new perspective on optimal care for patients with COPD. Prim Care Respir J (2011) 0.92
Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med (2008) 0.91
Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 0.90
Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise. Chest (2009) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Maximum exercise as an outcome in COPD: minimal clinically important difference. COPD (2005) 0.89
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.89
Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med (2010) 0.89
Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics (2003) 0.89
Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect Dis (2014) 0.87
Repeated psychological stress testing in stimulant-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.87
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD (2013) 0.86
Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding. Am J Med Genet B Neuropsychiatr Genet (2007) 0.86
Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 0.85